Interventions probably leads to higher death or dependence compared with conservative management (moderate certainty).
Interventions showed no clear difference in death Analysis 1.1 compared with control at end of intervention (low certainty).
Percutaneous vascular interventions showed no clear difference in death compared with intravenous thrombolytic treatment (low certainty).
Pharmaceutical interventions showed no clear difference in adverse events: 1. death: at end of treatment compared with placebo (moderate certainty).
It is very uncertain whether pharmacological interventions changes adverse events: death (secondary outcome) compared with placebo (very low certainty).
Endovascular thrombectomy interventions leads to lower death from all causes at the end of compared with standard therapy (high certainty).
It is very uncertain whether pharmacological interventions (antidepressants) changes adverse events: death ‐ at end of treatment Analysis 1.12 compared with placebo (very low certainty).
It is very uncertain whether induced hypertension changes death or dependency (primary outcome) compared with placebo or no intervention (very low certainty).
The review found no eligible studies for this question.
It is very uncertain whether induced hypertension changes death from all causes (primary outcome) compared with placebo or no intervention (very low certainty).
It is very uncertain whether lowered blood pressure changes death from all causes (primary outcome) compared with placebo (very low certainty).
It is very uncertain whether pharmacological intervention and non‐invasive brain stimulation… changes adverse events: death (secondary outcome) compared with a pharmacological intervention and sham stimulation or usual care… (very low certainty).
It is very uncertain whether psychological therapy changes adverse events: death ‐ at end of treatment (Analysis 2.16) compared with usual care and/or attention control (very low certainty).
It is very uncertain whether psychological therapy changes adverse events: death ‐ at end of treatment (secondary outcome) compared with usual care and/or attention control (very low certainty).